[The pharmacogenetics of hypoglycemia and the glycemic variability at the patients ith type 2 diabetes mellitus].
N A ChernikovaL L KamyninaA S AmetovDmitry Alekseevich SychevElena A GrishinaKristina Anatolyevna AkmalovaPublished in: Terapevticheskii arkhiv (2020)
At the real clinical practice the assessment of carriage of SNPs of geneCYP2C9before inclusion of SU to glucose-lowering scheme of T2DM-therapy it necessary to carry out for the detecting patients with a higher risk of hypoglycemia and rising of Glycemic Variability.
Keyphrases
- glycemic control
- type diabetes
- end stage renal disease
- blood glucose
- clinical practice
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- insulin resistance
- genome wide
- cardiovascular disease
- dna methylation
- adipose tissue
- weight loss
- patient reported outcomes
- cell therapy
- skeletal muscle
- replacement therapy